Analysis of renal function in patients after scheduled orthopedic intervention on lower limb joints in real clinical practice
- Authors: Trushina O.Y.1, Okisheva E.А.1, Solonina A.D.1, Sorokina S.A.1, Panferov A.S.1, Elizarov M.P.1, Lychagin A.V.1, Fomin V.V.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 27, No 10 (2025): Cardiology and nephrology
- Pages: 609-613
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/352923
- DOI: https://doi.org/10.26442/20751753.2025.10.203438
- ID: 352923
Cite item
Full Text
Abstract
Background. Osteoarthritis (OA) with severe pain syndrome is the main reason for total arthroplasty of lower extremity joints. Majority of patients with OA are elderly people with comorbidities who take multiple medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), that increases the risk of renal dysfunction.
Aim. To evaluate the frequency of renal dysfunction in patients undergoing scheduled arthroplasty of lower extremity joints in real clinical practice, the impact of NSAIDs and pain syndrome.
Materials and methods. The study included 1493 patients who underwent scheduled arthroplasty of the hip or knee joint. All patients provided information on concomitant diseases, previously prescribed therapy, pain severity on a ten-point scale and need for NSAIDs; serum creatinine level was assessed and glomerular filtration rate (GFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula with determination of the stage of chronic kidney disease (CKD). At 1, 3 and 6 months after surgery, patients were contacted and pain severity and need for NSAIDs were assessed.
Results. The study population included 636 men (42.6%) and 857 women (57.4%). Of these, 84.9% of patients were taking NSAIDs. The mean preoperative GFR was 73.2 ± 15.2 ml/min/1.73 m2 (14.3% of patients had CKD stage 3a, 4.8% – CKD stage 3b, and 0.3% – CKD stage 4). The median pain score before surgery was 8 [7; 9] points, and after 3 months it was 1 [0; 3] point. During the study period, 54 patients were readmitted for scheduled arthroplasty on the second joint. In this sample, an increase in GFR (p < 0.001) and a decrease in the CKD stage (p < 0.001) were found, that correlated with less pain compared to the first surgery and a decrease in the need for NSAIDs (r = 0.684; p < 0.001).
Conclusion. Patients undergoing scheduled surgical treatment of OA are characterized by a high incidence of CKD and a significant burden of NSAIDs. In the postoperative period, a decrease in pain severity, use of NSAIDs and a statistically significant relationship between these factors with an increase in GFR and a decrease in the stage of CKD are found. This confirms the need to implement non-drug pain relief methods and patient education for OA.
Full Text
##article.viewOnOriginalSite##About the authors
Olga Yu. Trushina
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-5820-1759
D. Sci. (Med.)
Russian Federation, MoscowElena А. Okisheva
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: e.okisheva@gmail.com
ORCID iD: 0000-0003-2977-7203
Cand. Sci. (Med.)
Russian Federation, MoscowAlyona D. Solonina
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0009-0007-3017-8327
Student
Russian Federation, MoscowSvetlana A. Sorokina
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0009-0002-9575-6646
Student
Russian Federation, MoscowAlexander S. Panferov
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-4324-7615
Cand. Sci. (Med.)
Russian Federation, MoscowMikhail P. Elizarov
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-4811-5718
Orthopedic Traumatologist
Russian Federation, MoscowAlexey V. Lychagin
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2202-8149
D. Sci. (Med.), Prof.
Russian Federation, MoscowVictor V. Fomin
Sechenov First Moscow State Medical University (Sechenov University)
Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2682-4417
D. Sci. (Med.), Prof., Acad. RAS
Russian Federation, MoscowReferences
- Портянникова О.О., Цвингер С.М., Говорин А.В., Романова Е.Н. Анализ распространенности и факторов риска развития остеоартрита в популяции. Современная ревматология. 2019;13(2):105-11 [Portyannikova OO, Tsvinger SM, Govorin AV, Romanova EN. Analysis of the prevalence and risk factors of osteoarthritis in a population. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(2):105-11 (in Russian)]. doi: 10.14412/1996-7012-2019-2-105-111
- Ferguson RJ, Palmer AJ, Taylor A, et al. Hip replacement. Lancet. 2018;392(10158):1662-71. doi: 10.1016/S0140-6736(18)31777-X
- Лычагин А.В., Гаркави А.В., Мещеряков В.А., и др. Остеоартроз коленного сустава у пожилых – всегда ли оправдано эндопротезирование? Вестник Российского государственного медицинского университета. 2019;2:77-82 [Lychagin AV, Garkavi AV, Meshcheryakov VA, et al. Osteoarthritis of the knee joint in the elderly: Is endoprosthetics always justified? Bulletin of the Russian State Medical University. 2019;2:77-82 (in Russian)]. doi: 10.24075/vrgmu.2019.020
- Божкова С.А., Тихилов Р.М., Андрияшкин В.В., и др. Профилактика, диагностика и лечение тромбоэмболических осложнений в травматологии и ортопедии: методические рекомендации. Травматология и ортопедия России. 2022;28(3):136-66 [Bozhkova SA, Tikhilov RM, Andryashkin VV, et al. Prevention, diagnosis and treatment of thromboembolic complications in traumatology and orthopedics: Guidelines. Travmatologiya i ortopediya Rossii = Traumatology and Orthopedics of Russia. 2022;28(3):136-66 (in Russian)]. doi: 10.17816/2311-2905-1993
- Окишева Е.А., Миронова О.Ю., Мадоян М.Д., и др. Медикаментозная терапия сердечно-сосудистых заболеваний у пациентов, госпитализированных для планового эндопротезирования крупных суставов: анализ реальной клинической практики. Consilium Medicum. 2023;25(1):34-8 [Okisheva EA, Mironova OIu, Madoyan MD, et al. Cardiovascular therapy in patients hospitalized for elective large joint arthroplasty: Real-world practice review. Consilium Medicum. 2023;25(1):34-8 (in Russian)]. doi: 10.26442/20751753.2023.1.202097
- Baker M, Perazella MA. NSAIDs in CKD: Are they safe? Am J Kidney Dis. 2020;76(4):546-57. doi: 10.1053/j.ajkd.2020.03.023
- Чеботарева Н.В., Лысенко Л.В. Поражение почек, ассоциированное с нестероидными противовоспалительными препаратами. Нефрология и диализ. 2022;24(3):431-40 [Chebotareva NV, Lysenko LV. Kidney injury associated with non-steroid anti-inflammatory drugs. Nephrology and Dialysis. 2022;24(3):431-40 (in Russian)]. doi: 10.28996/2618-9801-2022-3-431-440
- Аксенова А.В., Ощепкова Е.В., Чазова И.Е. Антигипертензивная терапия у коморбидных больных с артериальной гипертонией в условиях реальной клинической практики (по данным национального регистра артериальной гипертонии, 2019–2022 гг.). Терапевтический архив. 2024;96(9):860-71 [Aksenova AV, Oschepkova EV, Chazova IE. Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022). Terapevticheskii Arkhiv (Ter. Arkh.). 2024;96(9):860-71 (in Russian)]. doi: 10.26442/00403660.2024.09.202848
- Кобалава Ж.Д., Виллевальде С.В., Боровкова Н.Ю., и др. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией: результаты эпидемиологического исследования ХРОНОГРАФ. Кардиология. 2017;57(10):39-44 [Kobalava ZhD, Villevalde SV, Borovkova NYu, et al. Prevalence of markers of chronic kidney disease in patients with arterial hypertension: Results of epidemiological trial CHRONOGRAF. Kardiologiia. 2017;57(10):39-44 (in Russian)]. doi: 10.18087/cardio.2017.10.10041
- Qiangqiang Li, Bingyang Dai, Yao Y, et al. Chronic kidney dysfunction can increase the risk of deep vein thrombosis after total hip and knee arthroplasty. Biomed Res Int. 2017;2017:8260487. doi: 10.1155/2017/8260487
- Kalafutova S, Juraskova B, Vlcek J. The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure. Adv Clin Exp Med. 2014;23(6):993-1000. doi: 10.17219/acem/37357
- Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т., и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56(S1):1-29 [Karateev AE, Nasonov EL, Ivashkin VT, et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018;56(S1):1-29 (in Russian)]. doi: 10.14412/1995-4484-2018-1-29
- Окишева Е.А., Трушина О.Ю., Мадоян М.Д., и др. Особенности терапевтического мониторинга после планового эндопротезирования коленного и тазобедренного суставов в условиях реальной клинической практики: одноцентровое проспективное когортное исследование. Сибирский журнал клинической и экспериментальной медицины. 2025;40(1):120-6 [Okisheva EA, Trushina OIu, Madoyan MD, et al. Real-world therapeutic monitoring after elective total knee and hip arthroplasty: Single-center prospective cohort study. Siberian Journal of Clinical and Experimental Medicine. 2025;40(1):120-6 (in Russian)]. doi: 10.29001/2073-8552-2025-40-1-120-126
- Лила А.М., Алексеева Л.И., Таскина Е.А., и др. Клинические рекомендации (проект) по диагностике и лечению первичного остеоартрита для специалистов первичного звена (врачей-терапевтов, врачей общей практики). Терапия. 2023;9(1):7-22 [Lila AM, Alekseeva LI, Taskina EA, et al. Clinical guidelines (draft) for the diagnosis and treatment of primary osteoarthritis for primary care specialists (therapists, general practitioners). Terapiya. 2023;9(1):7-22 (in Russian)]. doi: 10.18565/therapy.2023.1.7-22
- Curtis E, Fuggle N, Shaw S, et al. Safety of cyclooxygenase-2 inhibitors in osteoarthritis: Outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl. 1):25-44. doi: 10.1007/s40266-019-00664-x
Supplementary files


